The mechanism by which blood transfusions given before renal transplantation improves allograft survival was studied in 31 transplant recipients. The presence of non-cytotoxic, Fc receptor blocking antibodies to donor and leukaemic B lymphocytes in pre-transplant sera correlated with both improved graft survival (p<0 ·03 and <0·1, respectively) and the number of blood transfusions given (p<0 ·05 and <0 ·03, respectively). Moreover, 6 out of 10 previously untransfused prospective transplant recipients developed these potentially protective antibodies during a course of elective blood transfusions. These results indicate that such non-cytotoxic, Fc receptor blocking antibodies in pretransplant recipient sera (a) are associated with improved allograft survival, (b) correlate with the number of blood transfusions given, and (c) can develop in response to blood transfusion.
MacLeod, A. M., Mason, R. J., Shewan, W. G., Power, D. A., Stewart, K. N., Edward, N., & Catto, G. R. D. (1982). Possible mechanism of action of transfusion effect in renal-transplantation. The Lancet, 2(8296), 468-470. https://doi.org/10.1016/S0140-6736(82)90496-2